On December 4, 2006, the US Food and Drug Administration (FDA) sent out five warning letters to compounding pharmacies regarding the sale of compunded topical anesthetics. These products are sometimes used for hair removal.
According to FDA, “There have been at least two non-fatal reactions and two deaths attributed to the use of compounded topical local anesthetic creams containing high doses of local anesthetics.”
Hairfacts has compiled this list:
Tiberius Inc. Custom Scripts Pharmacy (Tampa, FL)
-Betacaine LA ointment
http://www.fda.gov/foi/warning_letters/g6145d.htm
Hal’s Compounding Pharmacy, Inc. (San Diego, CA)
-Anesthetic Skin Lotion
-Tetracaine 6% in DMSO Gel
-Triple Kwick Anesthetic Gel
-NEW* topical anesthetic
-Kwick Anesthetic Gel
-Lidocaine and Tetracaine Demi Gel
-Anesthetic Skin Gel 3+
http://www.fda.gov/foi/warning_letters/g6146d.htm
New England Compounding Center (Framingham, MA)
-Extra Strength Triple Anesthetic Cream
http://www.fda.gov/foi/warning_letters/g6147d.htm
Triangle Compounding Pharmacy (Cary, NC)
-Lasergel
-Lasergel Plus 10/10 (“associated with the death of a 22 year old female on January 5, 2005.”)
http://www.fda.gov/foi/warning_letters/g6144d.htm
University Pharmacy (Salt Lake City, UT)
-Photocaine gel (“associated with the death of a 25 year old female on November 1, 2004.”)
http://www.fda.gov/foi/warning_letters/g6143d.htm
For more on the possible risks of pain management with these and other methods, see this page on hairfacts: